P300/CBP-HAT-INHIBITOREN

Patent europeic · EP3752250 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3752250
Numer da la dumonda
EP19708731
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
15-02-2019
Publitgà
23-12-2020
Concedì
03-08-2022
Stritgà
23-09-2023
Motiv
Taxa annuala betg pajada
Classas IPC
A61P 11/00 (2006.01)
A61P 3/00 (2006.01)
A61P 9/00 (2006.01)
A61P 29/00 (2006.01)
A61P 35/00 (2006.01)
A61P 31/12 (2006.01)
C07D 403/12 (2006.01)
A61K 31/337 (2006.01)
A61K 31/38 (2006.01)
A61K 31/397 (2006.01)
A61K 31/4025 (2006.01)
A61K 31/404 (2006.01)
A61K 31/4155 (2006.01)
A61K 31/4162 (2006.01)
A61K 31/4184 (2006.01)
A61K 31/4188 (2006.01)
A61K 31/4192 (2006.01)
A61K 31/4196 (2006.01)
A61K 31/4355 (2006.01)
A61K 31/454 (2006.01)
Prioritad
US 201862631594 P 16.02.2018
US 201862758867 P 12.11.2018
Dumonda PCT
PCT/US2019/018150 15.02.2019
Publicaziun PCT
WO2019/161157 22.08.2019
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-09-2023

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.09.2023

  2. 14-06-2023

    Midada

    Published in Swissreg on 14.06.2023

  3. 03-08-2022

    Concedì

    Published in Swissreg on 03.08.2022

Partidas

Possessur

Constellation Pharmaceuticals, Inc.

215 First Street, Suite 200, Cambridge, MA 02142, US

Inventur

WILSON, Jonathan, E.

Arlington, MA 02474, US

LEVELL, Julian, R.

Arlington, MA 02474, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.